3D Structure Inspector
Structure Overview
Ligand Interactions

2AW1 - Overview - 3D Structure Inspector

Atoms
Solvent
Spheres
Surface
Colour
Opacity
Texture
Background

LeftMouse Rotate
Shift+Left Scale
Ctrl+Left Translate
Click Select
+,− Clipping
r Reset view

AstexViewer™ Copyright (C) 1999-2007 Astex Therapeutics Ltd.
OpenAstexViewer Copyright (C) 2007-2014 Mike Hartshorn





Display Compound Structure Het Het Names Het Formula
COX
Bextra
COX
SC-65872
VALDECOXIB
Valdecoxib
4-(5-METHYL-3-PHENYLISOXAZOL-4-YL)BENZENESULFONAMI...
C16 H14 N2 O3 S
HGB
HGB
P-(Hydroxymercurio)Benzoate
Para-Hydroxymercuribenzoic Acid
Para-Hydroxymercuribenzoic acid
4-(HYDROXYMERCURY)BENZOIC ACID
C7 H6 Hg O3
GOL
CRY
E422
GLYCERIN
GOL
Glycerin
Glycerol
Glycogelatin
Keybells
MONOCTANOIN COMPONENT D
Monoctanoin Component D
Nirolex
Ophthalgan
Optim
Osmoglyn
Procalamine
Senokot Direct Relief
Tixylix Baby
Tixylix Toddler
Waterhouse
GLYCEROL
C3 H8 O3
ZN
/ZN
ZINC ION
ZN
ZN2
ZINC ION
Zn
PDB Code2AW1
TitleCARBONIC ANHYDRASE INHIBITORS: VALDECOXIB BINDS TO A DIFFERENT ACTIVE SITE REGION OF THE HUMAN ISOFORM II AS COMPARED TO THE STRUCTURALLY RELATED CYCLOOXYGENASE II "SELECTIVE" INHIBITOR CELECOXIB
Deposition
Release
Last Modified
ObsoleteNo
ClassificationLYASE
Experiment TypeX-RAY DIFFRACTION
Space GroupP 1 21 1
Resol Range High1.46
Resol Range Low20
Pubmed Id16290146
Doi10.1016/J.BMCL.2005.09.040
PDB Chain2AW1_A (click to show/hide)